Prediction and control effectiveness and safety of a drug by means of pharmacokinetics based on physiological and biochemical mechanism of its disposition in body.
Prediction and control effectiveness and safety of a drug by means of pharmacokinetics based on physiological and biochemical mechanism of its disposition in body.
批准号:
05302061
负责人:
HANANO Manabu
金额:
$2.88万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Co-operative Research (A)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our studies on predition and control of drug disposition in body for promoting the effectiveness and safety by means of pharmacokinetics based on physiological and biochemical mechanism are summarized as follows. M.Hayashi evaluated and promoted intestinal absorption of drugs by using rat intestinal duct and Caco-2 cell. M.Hashida presented a new technology in order to clarify mechanism of drug absorption and to promote it. A.Tsuji clarified mechanism of drug transport through cell membrane and developed the regulation successfully. K.Inui analyzed precisely mechanism of tubular secretion of drug by using cultured urinal epidermal cell. S.Awazu clarified molecular mechanism of appearance of drug toxic action. J.Watanabe and N.Yata succeeded prediction of tissue distribution in macro molecular compounds and in basic drugs, respectively. T.Terasaki analyzed and clarified transport into tissue of virus based on the receptor distribution in tissues and cell killing kinetics of anticancer drugs including DNA topoisomerase I and II.T.Iga succeeded prediction neurotoxic convolution by histamine H_2 receptor antagonists. S.Higuchi developed individualized dosing by using population kinetics model. Y.Sugiyama succeeded regulation of a receptor mediated clearance of biologically active macromolecule. M.Hanano generalized the whole studies and analyzed relationship between pharmacokinetics and action for analgesics in order to develop pharmacokinetics based on physiological and biochemical mechanism invoived by drug effective and its toxicity. These significant results were presented to open seminar held on September 26th in 1994 at Yasuda hall in the university of Tokyo, Hongo Tokyo Japan.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A.Tsuji: "Restricted transport of cyclosporin A across the blood brain barrier by a multidrug transporter,P-glycoprotein." Biochem.Pharmacol.46. 1096-1099 (1993)
A.Tsuji:“通过多药转运蛋白 P-糖蛋白限制环孢菌素 A 穿过血脑屏障的转运。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
下川昌文: "H_2受容体遮断薬による中枢性副作用の薬物動態論的評価:危険因子としての肝、腎疾患" 薬物動態. 8. 295-305 (1993)
Masafumi Shimokawa:“H_2 受体阻滞剂引起的中枢副作用的药代动力学评估:肝脏和肾脏疾病作为危险因素” Pharmacokinetics 8. 295-305 (1993)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.X.Liu: "Decrease in the hepatic uptake clearance of hepatocyte growth factor(HGF)in CCl_4-intoxicated rats." Hepatology. 17. 651-660 (1993)
K.X.Liu:“CCl_4 中毒大鼠肝细胞生长因子 (HGF) 的肝脏摄取清除率降低。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Saito: "Dipeptide transporters in the apical and basolateral membranes of the human intestinal cell line,Caco-2." Am.J.Physiol.265. G289-G294 (1993)
H.Saito:“人肠细胞系 Caco-2 顶膜和基底外侧膜中的二肽转运蛋白。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Mizuma: "Comparative study of active absorption by the intestine and disposition of anomers of sugar-conjugated compounds.21GC05:Biochem.Pharmacol." 45. 1520-1523 (1993)
T.Mizuma:“肠道主动吸收和糖缀合化合物端基异构体处置的比较研究。21GC05:Biochem.Pharmacol。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Kinetical analysis of pharmacodynamics based on drug-receptor interactions
-
批准号:62460215
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1987
-
负责人:HANANO Manabu
-
依托单位:
Comprehensive study on the predition of drug disposition based on the physiological and anatomical mechanism.
-
批准号:60304083
-
项目类别:Grant-in-Aid for Co-operative Research (A)
-
资助金额:$8.45万
-
财政年份:1985
-
负责人:HANANO Manabu
-
依托单位:
Development of a simple and rapid determination method of <alpha_1> -acid glycoprotein in plasma.
-
批准号:59870077
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$5.38万
-
财政年份:1984
-
负责人:HANANO Manabu
-
依托单位:
海外基金